scholarly journals Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study

Rheumatology ◽  
2020 ◽  
Vol 59 (9) ◽  
pp. e46-e47 ◽  
Author(s):  
Ryu Watanabe
Keyword(s):  
Takayasu Arteritis ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Randomized Controlled ◽  
Term Efficacy

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

2019 ◽  
Vol 3 ◽  
pp. S25
Author(s):  
Benjamin Ehst ◽  
George Han ◽  
Scott Guenthner ◽  
Kimberly Eads ◽  
Abby Jacobson
Keyword(s):  
Disease Duration ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Two Phase ◽  
Term Efficacy

Abstract not available.

scholarly journals Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials

2018 ◽  
Vol 38 (8) ◽  
pp. 864-875 ◽  
Author(s):  
Stephen Jolles ◽  
Mikhail A. Rojavin ◽  
John-Philip Lawo ◽  
Robert Nelson ◽  
Richard L. Wasserman ◽  
...  
Keyword(s):  
United States ◽  
Primary Immunodeficiency ◽  
The United States ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Term Efficacy
Sign in / Sign up

Export Citation Format

Share Document